Kangzhi Chen

Novel difluoromethylated 1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-indole derivatives as potent 5-HT6 receptor antagonist with AMDE-improving properties: Design, synthesis, and biological evaluation.

Jia Yu, Chuanfei Jin, Hai-Dong Liang, 2022, Bioorganic & medicinal chemistry.

Poor responses and adverse outcomes of myasthenia gravis after thymectomy: Predicting factors and immunological implications.

Huan Yang, Yi Li, Kangzhi Chen, 2022, Journal of autoimmunity.

Novel difluoromethyl-containing 1-((4-methoxy-3-(piperazin-1-yl)phenyl)sulfonyl)-1H-indole scaffold as potent 5-HT6R antagonists: Design, synthesis, biological evaluation, and early in vivo cognition-enhancing studies.

Tao Wang, Jia Yu, Chuanfei Jin, 2022, Bioorganic & medicinal chemistry.

The alteration of gut microbiome and metabolism in amyotrophic lateral sclerosis patients

Jinxia Zhou, Fangfang Bi, Qianqian Zeng, 2020, Scientific Reports.

Undervalued and novel roles of heterogeneous nuclear ribonucleoproteins in autoimmune diseases: Resurgence as potential biomarkers and targets

Zhaohui Luo, Huan Yang, Kangzhi Chen, 2023, Wiley interdisciplinary reviews. RNA.

Design, synthesis and evaluation of novel monoamine oxidase B (MAO-B) inhibitors with improved pharmacokinetic properties for Parkinson's disease.

Chuanfei Jin, Chao Yi, Kangzhi Chen, 2023, European journal of medicinal chemistry.

Deciphering Nonbioavailable Substructures Improves the Bioavailability of Antidepressants by Serotonin Transporter.

Biao Nie, Chuanfei Jin, Zhi-Zheng Wang, 2023, Journal of medicinal chemistry.